Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · September 10, 2022

Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using OGTT With and Without Confirmation Through HbA1c Testing

Circulation

 

Additional Info

Circulation
Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study
Circulation 2022 Aug 25;[EPub Ahead of Print], AG Tabák, EJ Brunner, JV Lindbohm, A Singh-Manoux, MJ Shipley, N Sattar, M Kivimäki

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading